The Compelling Role of Brain‐Derived Neurotrophic Factor Signaling in Multiple Sclerosis: Role of BDNF Activators

Hayder M. Al‐kuraishy,Ghassan M. Sulaiman,Hamdoon A. Mohammed,Salim Albukhaty,Ali K. Albuhadily,Ali I. Al‐Gareeb,Daniel J. Klionsky,Mosleh M. Abomughaid
DOI: https://doi.org/10.1111/cns.70167
2024-12-11
CNS Neuroscience & Therapeutics
Abstract:Brain‐derived neurotrophic factor (BDNF) is crucial for neuronal survival and plasticity in the CNS, acting through NTRK2/TRKB receptors. It also plays a role in inhibiting microglial activation and pro‐inflammatory cytokine release. This review examines the controversial BDNF levels in multiple sclerosis (MS) stages and explores how BDNF signaling and its modulators influence MS pathogenesis and outcomes. Brain‐derived neurotrophic factor (BDNF) is a neurotrophin, acting as a neurotrophic signal and neuromodulator in the central nervous system (CNS). BDNF is synthesized from its precursor proBDNF within the CNS and peripheral tissues. Through activation of NTRK2/TRKB (neurotrophic receptor tyrosine kinase 2), BDNF promotes neuronal survival, synaptic plasticity, and neuronal growth, whereas it inhibits microglial activation and the release of pro‐inflammatory cytokines. BDNF is dysregulated in different neurodegenerative diseases and depressions. However, there is a major controversy concerning BDNF levels in the different stages of multiple sclerosis (MS). Therefore, this review discusses the potential role of BDNF signaling in stages of MS, and how BDNF modulators affect the pathogenesis and outcomes of this disease.
pharmacology & pharmacy,neurosciences
What problem does this paper attempt to address?